AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease

Mark Goodman, Zhenling Liu,

Abstract

The cellular mechanisms of AMP-Activated Protein Kinase (AMPK) activators in the treatment and prevention of diabetes, cancer, and cardiovascular disease (Graphical abstract).

Relevant Publications in Pharmaceutical Regulatory Affairs: Open Access